Available to watch now, IBA Dosimetry explores prospective risk management with my QA PROactive
Want to learn more on this subject?
Prospective risk management, based on methods like FMEA or FTA risk assessments, represents a powerful approach to establishing a stronger safety culture within a clinic. By implementing guidelines such as the AAPM Task Group 100 report, risks can be effectively assessed, and the necessary corrective actions can be identified. The potential benefits of this approach extend beyond radiation therapy and can be applied to other fields like proton therapy and nuclear medicine. Clinicians face the challenge of carrying out this activity with limited existing resources while ensuring that the investment yields improved safety and workflow efficiency. The utilization of a dedicated software tool can significantly enhance the efficiency and effectiveness of this process. During the presentation, Benjamin Sintay, executive director of radiation oncology and chief physicist at Cone Health, will demonstrate the practical application of myQA PROactive software in conducting risk analysis within a community hospital. Additionally, David Menichelli from IBA Dosimetry R&D will discuss the integration of prospective risk analysis with incident reporting.
Benefits of attending:
- Gain insight into the importance of risk assessment
- Acquire knowledge on the seamless integration of risk assessment into regular clinical procedures
- Discover the tools that facilitate the implementation of a risk management program
- Develop an understanding of how incident reporting can be utilized to validate and enhance your ongoing risk analysis.
Want to learn more on this subject?
Benjamin “BJ” Sintay is the executive director of radiation oncology & chief physicist for Cone Health and co-founder & chief innovation officer for Fuse Oncology. Benjamin received bachelor of science degrees in electrical and computer engineering from North Carolina State University in 2004. He received a PhD in biomedical engineering from the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences in 2008. Benjamin is board certified in therapeutic medical physics by the American Board of Radiology. His interests include leader development, healthcare technology, radiotherapy quality & safety, software development, and product commercialization.
